Sol-Gel Technologies Ltd. - Investor Relations & Filings
Key figures FY2025
| Total Revenues | USD 19.39M | per the Annual Report filed 2026-03-19 |
|---|---|---|
| Net Income | USD -6.13M | per the Annual Report filed 2026-03-19 |
| Total Assets | USD 29.92M | per the Annual Report filed 2026-03-19 |
| Total Equity | USD 22.81M | per the Annual Report filed 2026-03-19 |
| Cash from Ops | USD 322.00k | per the Annual Report filed 2026-03-19 |
As reported by the issuer in the filings linked above. Figures are normalized for comparability; consult the source filing for the authoritative statement.
Sol-Gel Technologies Ltd. is a dermatology company that develops and commercializes topical treatments for skin conditions. The company leverages a proprietary, silica-based microencapsulation technology to stabilize active ingredients and enable controlled drug delivery. Its portfolio includes commercialized products for acne vulgaris and rosacea. The development pipeline focuses on addressing unmet needs in rare dermatological diseases, with a lead candidate, patidegib gel, for the prevention of new basal cell carcinoma lesions in patients with Gorlin syndrome. Other therapeutic areas of interest include pachyonychia congenita and hyperkeratosis-related indications. The company's strategy involves identifying and developing promising dermatological assets to provide innovative formulations for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 3 - Sol-Gel Technologies Ltd. (0001684693) (Issuer) | 2026-03-18 | English | |
| 3 - Sol-Gel Technologies Ltd. (0001684693) (Issuer) | 2026-03-18 | English | |
| 3 - Sol-Gel Technologies Ltd. (0001684693) (Issuer) | 2026-03-18 | English | |
| 4 - SOL-GEL TECHNOLOGIES LTD. (0001684693) (Filer) | 2026-02-18 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-01-29 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 32977437 | 3 - Sol-Gel Technologies Ltd. (0001684693) (Issuer) | 2026-03-18 | English | ||
| 32977426 | 3 - Sol-Gel Technologies Ltd. (0001684693) (Issuer) | 2026-03-18 | English | ||
| 32977407 | 3 - Sol-Gel Technologies Ltd. (0001684693) (Issuer) | 2026-03-18 | English | ||
| 32896618 | 4 - SOL-GEL TECHNOLOGIES LTD. (0001684693) (Filer) | 2026-02-18 | English | ||
| 31300772 | 4 Filing | 2026-02-04 | English | ||
| 31300798 | 4 Filing | 2026-01-29 | English | ||
| 31300779 | 4 Filing | 2026-01-23 | English | ||
| 12985498 | Regulatory Filings 2026 | 2026-01-15 | English | ||
| 12985499 | 4 | 2026-01-06 | English | ||
|
2025
6 filings
| |||||
| 12985500 | Director's Dealing 2025 | 2025-12-31 | English | ||
| 12985501 | 4 | 2025-12-29 | English | ||
| 12985502 | 4 | 2025-12-19 | English | ||
| 12985504 | 6-K | 2025-12-17 | English | ||
| 12985503 | 4 | 2025-12-16 | English | ||
| 12985506 | 4 | 2025-12-09 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Sol-Gel Technologies Ltd., but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available - coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
| 4D Pharma PLC | DDDD | GB | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
Sol-Gel Technologies Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34322/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34322 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing - metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34322 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34322 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34322}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sol-Gel Technologies Ltd. (id: 34322)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.